UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 251

Sortiert nach

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

Breast cancer research and treatment, 2019-04, Vol.174 (3), p.719-729

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes in patients (pts) with estrogen receptor–positive (ER+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC) with objective response (OR) or without objective response (non-OR) in PALOMA-2

Annals of oncology, 2018-10, Vol.29, p.viii107-viii108

2018

Link zum Volltext

Verfügbarkeit prüfen

Synbiotics in the Management of Pediatric Gastrointestinal Disorders: Position Paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications

Journal of pediatric gastroenterology and nutrition, 2023-01, Vol.76 (1), p.102-108

2023

Link zum Volltext

Verfügbarkeit prüfen

Increasing access to palliative care for patients with advanced cancer of African and Latin American descent: a patient-oriented community-based study protocol

BMC palliative care, 2023-12, Vol.22 (1), p.204-204, Article 204

2023

Link zum Volltext

Verfügbarkeit prüfen

Melanoma brain metastases patients treated with stereotactic radiosurgery and ipilimumab versus stereotactic radiosurgery alone: a systematic review with meta-analysis

Annals of oncology, 2017-09, Vol.28, p.v414-v415

2017

Link zum Volltext

Verfügbarkeit prüfen

Melanoma brain metastases patients treated with stereotactic radiosurgery and ipilimumab versus stereotactic radiosurgery alone: a systematic review with meta-analysis

Annals of oncology, 2017-09, Vol.28, p.v414-v414

2017

Link zum Volltext

Verfügbarkeit prüfen

P2.01-056 Use of Cell-Free Circulating RNA (cfRNA) Expression of PD-L1 and ERCC1 in Plasma to Monitor Response to Therapy in NSCLC

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2090-S2091

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of prior treatment on palbociclib plus letrozole (P+L) efficacy and safety in patients (pts) with estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2–) first-line advanced breast cancer (ABC): A PALOMA-2 subgroup analysis

Annals of oncology, 2017-09, Vol.28, p.v79-v80

2017

Link zum Volltext

Verfügbarkeit prüfen

470 Final results of a phase II study of combination with nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy in patients with HER2-negative metastatic breast cancer

European journal of cancer supplements, 2010, Vol.8 (3), p.196-196

2010

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-21-25: Efficacy and safety of palbociclib (PAL) + letrozole (LET) as first-line therapy in estrogen receptor–positive (ER+)/human epidermal growth factor receptor 2–negative (HER2−) advanced breast cancer (ABC): Findings by geographic region from PALOMA-2

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-21-25

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-21-03: Palbociclib (PAL) + letrozole (LET) as first-line therapy in estrogen receptor–positive (ER+)/human epidermal growth factor receptor 2–negative (HER2−) advanced breast cancer (ABC): Efficacy and safety updates with longer follow-up across patient subgroups

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-21-03

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-12-07: Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of patients with HER2-positive metastatic breast cancer with progression in the CNS after trastuzumab (TRIO-US B-09)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-12-07

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-22-09: A phase 2 open label study of everolimus in combination with endocrine therapy in resistant hormone receptor-positive HER2-negative advanced breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P4-P4-22-09

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P3-14-01: Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients with HER2+ early-stage breast cancer: The CONTROL trial

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P3-P3-14-01

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-16-19: Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancer

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P5-P5-16-19

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P2-02-16: Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P2-P2-02-16

2018

Link zum Volltext

Verfügbarkeit prüfen

Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation

Heart rhythm, 2005-05, Vol.2 (5), p.525-529

2005

Link zum Volltext

Verfügbarkeit prüfen

332PClinical outcomes in patients (pts) with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) with objective response (OR) or without objective response (non-OR) in PALOMA-2

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Emotion Dynamics Across Adulthood in Everyday Life: Older Adults Are More Emotionally Stable and Better at Regulating Desires

Emotion (Washington, D.C.), 2021-04, Vol.21 (3), p.453-464

2021

Link zum Volltext

Verfügbarkeit prüfen

Joint modeling of arrivals and parking durations for freight loading zones: Potential applications to improving urban logistics

Transportation research. Part A, Policy and practice, 2022-12, Vol.166, p.307-329

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of freight curbside management on sustainable cities: Evidence and paths forward

Transportation research. Part D, Transport and environment, 2024-05, Vol.130, p.104165, Article 104165

2024

Link zum Volltext

Verfügbarkeit prüfen

Novel Strategies to Improve the Endocrine Therapy of Breast Cancer

Oncology Reviews, 2017-05, Vol.11 (1), p.323-323

Castrellon, Aurelio Bartolome

2017

Link zum Volltext

Verfügbarkeit prüfen

The Role of CD4/6 Inhibitors in Breast Cancer Treatment

International journal of molecular sciences, 2024-01, Vol.25 (2), p.1242

2024

Link zum Volltext

Verfügbarkeit prüfen

Probiotic Effect on SARS‐CoV2 Immunity Is Associated to Type‐1 Interferons: A Post‐Hoc Analysis of a Randomized, Placebo‐Controlled Trial

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 251

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

Clinical outcomes in patients (pts) with estrogen receptor–positive (ER+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC) with objective response (OR) or without objective response (non-OR) in PALOMA-2

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

Synbiotics in the Management of Pediatric Gastrointestinal Disorders: Position Paper of the ESPGHAN Special Interest Group on Gut Microbiota and Modifications

Increasing access to palliative care for patients with advanced cancer of African and Latin American descent: a patient-oriented community-based study protocol

Melanoma brain metastases patients treated with stereotactic radiosurgery and ipilimumab versus stereotactic radiosurgery alone: a systematic review with meta-analysis

Melanoma brain metastases patients treated with stereotactic radiosurgery and ipilimumab versus stereotactic radiosurgery alone: a systematic review with meta-analysis

P2.01-056 Use of Cell-Free Circulating RNA (cfRNA) Expression of PD-L1 and ERCC1 in Plasma to Monitor Response to Therapy in NSCLC

Impact of prior treatment on palbociclib plus letrozole (P+L) efficacy and safety in patients (pts) with estrogen receptor-positive/human epidermal growth factor receptor 2-negative (ER+/HER2–) first-line advanced breast cancer (ABC): A PALOMA-2 subgroup analysis

470 Final results of a phase II study of combination with nab-paclitaxel, bevacizumab, and gemcitabine as first-line therapy in patients with HER2-negative metastatic breast cancer

Abstract P5-21-25: Efficacy and safety of palbociclib (PAL) + letrozole (LET) as first-line therapy in estrogen receptor–positive (ER+)/human epidermal growth factor receptor 2–negative (HER2−) advanced breast cancer (ABC): Findings by geographic region from PALOMA-2

Abstract P5-21-03: Palbociclib (PAL) + letrozole (LET) as first-line therapy in estrogen receptor–positive (ER+)/human epidermal growth factor receptor 2–negative (HER2−) advanced breast cancer (ABC): Efficacy and safety updates with longer follow-up across patient subgroups

Abstract P1-12-07: Phase Ib/II single-arm trial evaluating the combination of everolimus, lapatinib and capecitabine for the treatment of patients with HER2-positive metastatic breast cancer with progression in the CNS after trastuzumab (TRIO-US B-09)

Abstract P4-22-09: A phase 2 open label study of everolimus in combination with endocrine therapy in resistant hormone receptor-positive HER2-negative advanced breast cancer

Abstract P3-14-01: Effects of adding budesonide or colestipol to loperamide prophylaxis on neratinib-associated diarrhea in patients with HER2+ early-stage breast cancer: The CONTROL trial

Abstract P5-16-19: Evaluation of weekly paclitaxel plus carboplatin followed by anthracycline chemotherapy on the neoadjuvant treatment of patients with triple-negative breast cancer

Abstract P2-02-16: Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients

Digoxin use is associated with increased platelet and endothelial cell activation in patients with nonvalvular atrial fibrillation

332PClinical outcomes in patients (pts) with estrogen receptor-positive (ER+)/human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) with objective response (OR) or without objective response (non-OR) in PALOMA-2

Emotion Dynamics Across Adulthood in Everyday Life: Older Adults Are More Emotionally Stable and Better at Regulating Desires

Joint modeling of arrivals and parking durations for freight loading zones: Potential applications to improving urban logistics

Effects of freight curbside management on sustainable cities: Evidence and paths forward

Novel Strategies to Improve the Endocrine Therapy of Breast Cancer

The Role of CD4/6 Inhibitors in Breast Cancer Treatment

Probiotic Effect on SARS‐CoV2 Immunity Is Associated to Type‐1 Interferons: A Post‐Hoc Analysis of a Randomized, Placebo‐Controlled Trial

Aktive Filter

Suchergebnisse filtern